232 related articles for article (PubMed ID: 10430972)
1. Influence of 5,10-methylenetetrahydrofolate reductase gene polymorphism on plasma homocysteine concentration in patients with end-stage renal disease.
Lee HA; Choi JS; Ha KS; Yang DH; Chang SK; Hong SY
Am J Kidney Dis; 1999 Aug; 34(2):259-63. PubMed ID: 10430972
[TBL] [Abstract][Full Text] [Related]
2. Methylenetetrahydrofolate reductase gene polymorphism, hyperhomocysteinemia, and cardiovascular diseases in chronic hemodialysis patients.
Morimoto K; Haneda T; Okamoto K; Ishida H; Kikuchi K
Nephron; 2002 Jan; 90(1):43-50. PubMed ID: 11744804
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.
Lim PS; Hung WR; Wei YH
Nephron; 2001 Mar; 87(3):249-56. PubMed ID: 11287760
[TBL] [Abstract][Full Text] [Related]
4. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
[TBL] [Abstract][Full Text] [Related]
5. [Methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in hemodialysing patients].
Yao Y; Liu H; Zhang X; Duan X
Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):522-5. PubMed ID: 12421498
[TBL] [Abstract][Full Text] [Related]
6. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.
Födinger M; Mannhalter C; Wölfl G; Pabinger I; Müller E; Schmid R; Hörl WH; Sunder-Plassmann G
Kidney Int; 1997 Aug; 52(2):517-23. PubMed ID: 9264011
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
[TBL] [Abstract][Full Text] [Related]
8. Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients.
Födinger M; Buchmayer H; Heinz G; Papagiannopoulos M; Kletzmayr J; Perschl A; Vychytil A; Hörl WH; Sunder-Plassmann G
Am J Kidney Dis; 2001 Jul; 38(1):77-84. PubMed ID: 11431185
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis.
Anwar W; Guéant JL; Abdelmouttaleb I; Adjalla C; Gérard P; Lemoel G; Erraess N; Moutabarrek A; Namour F
Clin Chem Lab Med; 2001 Aug; 39(8):747-52. PubMed ID: 11592445
[TBL] [Abstract][Full Text] [Related]
10. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
[TBL] [Abstract][Full Text] [Related]
11. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase gene C677T polymorphism, plasma homocysteine and folate in end-stage renal disease dialysis and non-dialysis patients.
Zychma MJ; Gumprecht J; Grzeszczak W; Zukowska-Szczechowska E;
Nephron; 2002 Sep; 92(1):235-9. PubMed ID: 12187113
[TBL] [Abstract][Full Text] [Related]
13. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
[TBL] [Abstract][Full Text] [Related]
14. Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese.
Moriyama Y; Okamura T; Kajinami K; Iso H; Inazu A; Kawashiri M; Mizuno M; Takeda Y; Sakamoto Y; Kimura H; Suzuki H; Mabuchi H
Atherosclerosis; 2002 Oct; 164(2):321-8. PubMed ID: 12204804
[TBL] [Abstract][Full Text] [Related]
15. The relation between erythrocyte volume and folate levels is influenced by a common mutation in the methylenetetrahydrofolate reductase (MTHFR) gene (C677T).
Lalouschek W; Aull S; Serles W; Wolfsberger M; Deecke L; Pabinger-Fasching I; Mannhalter C
J Investig Med; 2000 Jan; 48(1):14-20. PubMed ID: 10695265
[TBL] [Abstract][Full Text] [Related]
16. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
[TBL] [Abstract][Full Text] [Related]
17. Non-fasting reference intervals for the Abbott IMx homocysteine and AxSYM plasma folate assays: influence of the methylenetetrahydrofolate reductase 677 C-->T mutation on homocysteine.
Donnelly JG; Isotalo PA
Ann Clin Biochem; 2000 May; 37 ( Pt 3)():390-8. PubMed ID: 10817256
[TBL] [Abstract][Full Text] [Related]
18. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis.
Verhoeff BJ; Trip MD; Prins MH; Kastelein JJ; Reitsma PH
Atherosclerosis; 1998 Nov; 141(1):161-6. PubMed ID: 9863549
[TBL] [Abstract][Full Text] [Related]
19. Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease.
Dierkes J; Domröse U; Ambrosch A; Schneede J; Guttormsen AB; Neumann KH; Luley C
Metabolism; 1999 May; 48(5):631-5. PubMed ID: 10337865
[TBL] [Abstract][Full Text] [Related]
20. Vitamin B-12 status is inversely associated with plasma homocysteine in young women with C677T and/or A1298C methylenetetrahydrofolate reductase polymorphisms.
Bailey LB; Duhaney RL; Maneval DR; Kauwell GP; Quinlivan EP; Davis SR; Cuadras A; Hutson AD; Gregory JF
J Nutr; 2002 Jul; 132(7):1872-8. PubMed ID: 12097662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
